(USAUSW) UBS (Irl) - MSCI USA - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE00BD4TXS21 • US Large-Cap Blend Equity
USAUSW: Stocks, US, Equities
The UBS (Irl) ETF plc - MSCI USA UCITS ETF (USD) A-acc (SW:USAUSW) is designed to provide investors with exposure to the performance of the MSCI USA Index. This index tracks the performance of large and mid-cap companies in the United States, offering a broad representation of the US equity market. The fund employs a replication strategy, meaning it aims to hold the securities in the index in proportion to their weightings, allowing for cost-effective tracking of the underlying index.
As a UCITS-compliant ETF, this fund is structured to meet the regulatory requirements of the European Union, ensuring investor protection and transparency. It is domiciled in Ireland but listed on the SIX Swiss Exchange under the ticker symbol USAUSW. The fund is denominated in USD, which aligns with the currency of the underlying securities, minimizing currency risk for USD-based investors. The ETF is designed to replicate the net return performance of the MSCI USA Index after deducting fees and expenses, providing a clear and transparent investment proposition.
With an AUM of approximately $1.79 billion, this ETF offers a high level of liquidity, making it suitable for both institutional and retail investors. The funds expense ratio is typically in the range of 0.15% to 0.30%, which is competitive for a UCITS-compliant ETF tracking a broad US equity index. While the fund does not have a stated P/E ratio, the underlying index provides exposure to companies with a wide range of valuations, offering diversification across sectors and market capitalizations.
Investors should note that the ETFs market price may deviate slightly from its net asset value (NAV) due to market dynamics, though such deviations are generally small and temporary. The fund is listed on the SIX Swiss Exchange, allowing investors to trade it throughout the trading day, providing flexibility in execution. For more information, investors can visit the funds webpage at http://www.ubs.com/funds.
Additional Sources for USAUSW ETF
USAUSW ETF Overview
Market Cap in USD | 1,717m |
Category | US Large-Cap Blend Equity |
TER | 0.10% |
IPO / Inception | 2016-09-16 |
USAUSW ETF Ratings
Growth Rating | 73.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -1.22 |
Analysts | - |
Fair Price Momentum | 29.77 USD |
Fair Price DCF | - |
USAUSW Dividends
No Dividends PaidUSAUSW Growth Ratios
Growth Correlation 3m | -84.7% |
Growth Correlation 12m | 68.7% |
Growth Correlation 5y | 80.4% |
CAGR 5y | 14.86% |
CAGR/Max DD 5y | 0.58 |
Sharpe Ratio 12m | 1.58 |
Alpha | 0.24 |
Beta | 1.000 |
Volatility | 53.46% |
Current Volume | 94.4k |
Average Volume 20d | 28.8k |
As of April 16, 2025, the stock is trading at USD 31.36 with a total of 94,384 shares traded.
Over the past week, the price has changed by +4.83%, over one month by -3.97%, over three months by -8.90% and over the past year by +6.61%.
Yes. Based on ValueRay Analyses, UBS (Irl) - MSCI USA (SW:USAUSW) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.77 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USAUSW as of April 2025 is 29.77. This means that USAUSW is currently overvalued and has a potential downside of -5.07%.
UBS (Irl) - MSCI USA has no consensus analysts rating.
According to ValueRays Forecast Model, USAUSW UBS (Irl) - MSCI USA will be worth about 33.1 in April 2026. The stock is currently trading at 31.36. This means that the stock has a potential upside of +5.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 33.1 | 5.6% |